Cost-effectiveness of rapid laboratory-based mass-spectrometry diagnosis of bloodstream infection: evidence from the RAPIDO randomized controlled trial
<p><strong>Objectives and intervention:</strong> Bloodstream infection, the presence of viable microorganisms in the blood, is a prevalent clinical event associated with substantial mortality. Patient outcomes may be improved when the causative microorganism is identified quickly....
| Main Authors: | , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
BMJ
2021
|